english.prescrire.org > Spotlight > Archives : 2025 > Live attenuated cholera O1 vaccine (Vaxchora°)

Spotlight: Archives

Every month, the subjects in Prescrire’s Spotlight.

2025 : 1 | 30

Live attenuated cholera O1 vaccine (Vaxchora°)

 Marketing Authorisations  The mainstay of cholera prevention and control is to improve access to clean drinking water, sewage systems and personal hygiene. A live attenuated cholera O1 vaccine has been authorised in the European Union under the brand name Vaxchora°. For people living in countries where cholera is endemic or causes epidemics or travellers visiting such countries, is this vaccine more effective than the other available cholera vaccines? And what are its adverse effects?
Full article available for download by subscribers

 ©Prescrire 1 September 2025

Source: "Live attenuated cholera O1 vaccine (Vaxchora°)" Prescrire Int 2025; 34 (273): 201-205. Subscribers only.

Filet

Enjoy full access to Prescrire International, and support independent information

 

Share
Share on  Facebook  
 
 
See also:

"Cholera vaccine:
cholera too rare
in travellers to justify
vaccination"
Prescrire Int 2006;